Display Settings:

Format

Send to:

Choose Destination

    Tunis Med. 2008 Dec;86(12):1036-41.

    [Update in treatment of psoriatic arthritis]

    [Article in French]

    Abdelmoula LC, Ben M'Barek R, Yahia CB, Tekaya R, Testouri N, Chaabouni L, Zouari R.

    Service de rhumatologie, Hôpital Charles Nicolle, Tunis, Tunisie.

    Psoriatic arthritis is a chronic rheumatic disease making part of spondylarthropathies. It is the most frequent chronic inflammatory rheumatism after rheumatoid arthritis. Eventhough, it is usually a benign affection, it may be destructive leading to handicap. Several new medications have been introduced, including anti-tumor necrosis factor (TNF alpha blockers) and leflunomide for treatment of psoriatic arthritis. Many studies show the efficacy of these medications in this disease.

    PMID: 19213510 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Patient drug information

    • Leflunomide (Arava®)

      Leflunomide is used to treat rheumatoid arthritis. Leflunomide decreases the symptoms of rheumatoid arthritis and slows damage to joints caused by the disease.